FUNI (Hypha Labs) Shiller PE Ratio: (As of Aug. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hypha Labs Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Hypha Labs  (OTCPK:FUNI) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Hypha Labs Shiller PE Ratio Related Terms


Hypha Labs Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Hypha Labs's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypha Labs Shiller PE Ratio Chart

Hypha Labs Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Hypha Labs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FUNI vs ISPC, BIAF, IVRO: Shiller PE Ratio Comparison

For the Diagnostics & Research subindustry, Hypha Labs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hypha Labs Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hypha Labs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hypha Labs's Shiller PE Ratio falls into.



Hypha Labs Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hypha Labs's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Hypha Labs's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/333.9520*333.9520
=0.000

Current CPI (Jun. 2026) = 333.9520.

Hypha Labs Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -0.010 241.428 -0.014
201612 -0.010 241.432 -0.014
201703 -0.010 243.801 -0.014
201706 -0.010 244.955 -0.014
201709 -0.010 246.819 -0.014
201712 -0.010 246.524 -0.014
201803 -0.020 249.554 -0.027
201806 -0.010 251.989 -0.013
201809 0.000 252.439 0.000
201812 -0.010 251.233 -0.013
201903 -0.010 254.202 -0.013
201906 -0.010 256.143 -0.013
201909 -0.010 256.759 -0.013
201912 -0.005 256.974 -0.006
202003 -0.010 258.115 -0.013
202006 -0.010 257.797 -0.013
202009 -0.010 260.280 -0.013
202012 -0.010 260.474 -0.013
202103 0.000 264.877 0.000
202106 -0.003 271.696 -0.004
202109 0.000 274.310 0.000
202112 -0.006 278.802 -0.007
202203 -0.005 287.504 -0.006
202206 -0.010 296.311 -0.011
202209 -0.010 296.808 -0.011
202212 -0.003 296.797 -0.003
202303 -0.001 301.836 -0.001
202306 0.003 305.109 0.003
202309 0.000 307.789 0.000
202312 0.000 306.746 0.000
202403 0.000 312.332 0.000
202406 -0.010 314.175 -0.011
202409 -0.010 315.301 -0.011
202412 -0.010 315.605 -0.011
202503 0.000 319.799 0.000
202506 0.000 322.561 0.000
202509 0.000 324.800 0.000
202512 0.000 324.054 0.000
202603 0.000 330.213 0.000
202606 0.000 333.952 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hypha Labs Business Description

Address 5940 S. Rainbow Boulevard, Las Vegas, NV, USA, 89118
Hypha Labs Inc engaged in the research, development, and commercialization of the Hypha Micropearl accelerator, an in-home, web-based, computer-controlled bioreactor designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company's easy-to-use device, together with replaceable cartridges ordered through its exclusive app, safely and effectively produced enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contained active mushroom ingredients in a concentrated, easy-to-handle, tasteless, and odorless form that could be incorporated into various foods and beverages without altering flavor.